EMPLOYMENT AGREEMENTEmployment Agreement • February 23rd, 2016 • Regulus Therapeutics Inc. • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”) is made and entered into effective as of January 1, 2016 (the “Effective Date”), by and between Regulus Therapeutics Inc., a Delaware corporation (the “Company”), and Joseph P. Hagan (the “Executive”). The Company and the Executive are hereinafter collectively referred to as the “Parties”, and individually referred to as a “Party”.
LICENSING AGREEMENTLicensing Agreement • February 23rd, 2016 • Regulus Therapeutics Inc. • Pharmaceutical preparations
Licensor has developed certain Technology and owns certain Patents relating to oligonucleotides targeting miRNAs for the treatment of insulin resistance and type 2 diabetes. Licensor is desirous that such Technology and Patents be developed and exploited to the fullest possible extent so that their benefits can be enjoyed by the general public.
